Thus, further research is needed to measure serum IL-6 levels and NLR in patients with COVID-19 using an IL-6 cut-off of >6.99 pg/mL and NLR of >4.18, which can be included in the laboratory parameters for the management of patients with COVID-19. This evidence concerns the gene IL6 and COVID-19.